Babban Cholesterol da Ciwon sukari Hanya ne mai ƙyama ga mummunan zuciya
Masana kimiyya suna samun shaida cewa cutar tabarbare kanta tana ciwo da cholesterol , yana kara yawan yiwuwar ciwon zuciya ko bugun jini ko da ya fi girma. Abun da ke tsakanin waɗannan abubuwa biyu masu haɗari yana nufin cewa idan kun kasance masu ciwon sukari, dole ne ku yi hankali sosai game da ikon sarrafa kujin cholesterol.
Jirgin tsakanin Insulin da Cholesterol
Masu bincike suna ci gaba da gano yadda yadda ciwon sukari ya canza matakan cholesterol a matakin kwayoyin microscopic.
Sun san cewa matakan insulin a cikin jini sunyi tasiri sosai akan adadin ƙwayoyin cholesterol cikin jini.
Ayyukan insulin sunyi aiki don tada adadin LDL-cholesterol ("mummunar cholesterol") wanda ke nunawa a samar da launi a cikin arteries kuma ya rage yawan adadin cholesterol na HDL wanda ke taimakawa wajen kawar da alamomi mai hatsari kafin su karya kashe don ciwon zuciya ko bugun jini. Ciwon sukari kuma yana da tsayin daka haifar da matakan da ya fi girma a cikin jini, wani nau'in mai mai kewaya cikin jini.
Hakazalika, high cholesterol kuma zai iya kasancewa predictor na ciwon sukari; Hakanan ana ganin saurin ƙwayar cholesterol a cikin mutanen da ke da juriya na insulin, har ma kafin su ci gaba da ciwon sukari. Lokacin da LDL matakan fara hawa, masanan sun bada shawarar ba da hankali sosai ga sarrafa jini da kuma fara cin abinci da tsarin motsa jiki don taimakawa wajen kawar da ciwon sukari da cututtukan zuciya.
Wannan yana da mahimmanci idan kana da tarihin iyali na cututtukan zuciya.
Ga mutanen dake dauke da ciwon sukari na 1 , sarrafa jini zai iya yin babban bambanci. Kyakkyawan gwanin jini yana da alaka da matakan cholesterol na kusa-al'ada, kamar wadanda aka gani a cikin mutane ba tare da ciwon sukari ba. Amma mutanen da ke cike da ciwon sukari irin nau'in sun kara yawan matakan triglyceride da ƙananan matakan HDL, wanda ke taimakawa wajen ci gaba da ciwon daji.
Type 2 Ciwon sukari: Wani Musamman High Hadarin daga High Cholesterol
Mutane da ciwon sukari iri na 2 , duk da rashin kulawar jini, sun kasance sun karu triglycerides , sun rage HDL, wani lokaci kuma sun kara LDL. Wannan ƙwayar cholesterol zata iya jurewa ko da an sami ikon karfin jini - yana nuna zuwa ga mafi girma da alama na bunkasa plaques. A gaskiya ma, adadin da aka kafa a cikin jigilar mutane da irin ciwon sukari iri biyu sun fi yawanci da ƙasa da fibrous fiye da mutanen da ke fama da ciwon sukari na type 1, wanda zai haifar da mummunar haɗari da tayar da launi don haifar da ciwon zuciya ko bugun jini.
Ƙungiyar Ciwon Yankakken {asar Amirka na bayar da shawarar yin rajistar matakan cholesterol a kalla sau ɗaya a shekara, ko kuma sau da yawa idan suna da girma kuma ba a sarrafa su ba. Ga mutanen da ke da ciwon sukari da kuma cututtukan zuciya ba tare da saninsu ba, an bayar da shawarar cewa LDL matakan cikin jini ya kasance a kasa da digiri 100 a kowace deciliter (MG / DL), cewa matakan HDL sun kasance sama da 50 MG / dL, kuma triglycerides a kasa 150 mg / dL. Harshen jini da aka ba da shawara, ko glucose, matakin ya kasa da 7% (<7%) a gwajin HA1C.
Ga mutanen da ke fama da ciwon sukari da kuma cututtukan zuciya na zuciya da cututtukan zuciya, ciki har da suturar da aka katange ko ciwon zuciya na gaba, ADA yana bada shawarar LDL a kasa 70 MG / dL.
Samun wannan burin LDL mai ƙananan hali na iya buƙatar babban maganin magunguna, amma an nuna shi don rage haɗarin ciwon zuciya. Tsarin Triglyceride ya zama ƙasa da 150 mg / dL da HDL sama da 40 MG / dL. Matan da ke da ciwon sukari da kuma cututtukan zuciya na jijiyoyin cututtuka suna da shawarar su sami matakin HDL fiye da 50 MG / dL.
Ɗaya daga cikin maganin, WelChol (colesevelam), an nuna cewa ƙananan glucose da ƙwayar cholesterol sun kasance a cikin mutanen da ke fama da ciwon sukari na type 2. Ayyukan Welchol ne ta hanyar hana ƙwayoyin hanzari daga shayar da kwayoyin kifi daga abinci. Ko da yake Welchol yana ƙananan matakan LDL , zai iya haifar da matakan triglyceride a cikin jini, kuma kada mutane suyi amfani da haɗari masu ƙarfi.
Ciwon maganin ƙwayar cuta da Cholesterol
Mutanen da suke da rikici irin su insulin juriya, matakan cholesterol marasa ƙarfi, cutar hawan jini da kiba suna kwatanta da ciwon ciwon nakasar (wanda aka sani da ciwo X). Nazarin sun gano cewa marasa lafiya da low HDL da high triglycerides - alamun na ciwo na rayuwa - suna da mafi haɗari na fama da ciwon zuciya ko bugun jini. Mutanen da ke da wannan tasirin cholesterol kuma suna amfana da yawancin magunguna.
Hanyoyin da ke tattare da cututtukan zuciya na zuciya suna faruwa a hannu kuma ya kamata a bi da su tare. Mutane da ke fama da ciwon sukari - wadanda suke da mummunar haɗari na wata rana suna fama da ciwon zuciya - dole ne su kasance da hankali kan kiyaye dukkanin jini da cholesterol a ƙananan matakan. Har ila yau mahimmanci ne don kula da lafiyar lafiya da rage karfin jini kuma don kauce wa shan taba.
Sources:
Ƙungiyar Ciwon Yankakken Amirka. "Dokar ADA: Tsarin Magunguna a Ciwon sukari." Ciwon sukari Kulawa 30 (2007): Sanya 1.
McCulloch, David K. "Bayani na Kula da Magunguna a Adult da Diabetes Mellitus." UpToDate.com. 2008. UpToDate. 6 Afrilu 2008. (biyan kuɗi)
Meigs, James B. "Ciwo na Metabolic (Ciwon Lafiya na Insulin Resistance ko Ciwo X)." UpToDate.com. 2008. UpToDate. 7 Afrilu 2008. (biyan kuɗi)
Nesto, Richard W. "Tsarin Yaduwa da Hadarin Kwayoyi na Kwayoyin Kwayoyin zuciya na Ciwon sukari Mellitus." UpToDate.com. 2008. UpToDate. 6 Afrilu 2008. (biyan kuɗi)
Pyorala, K., et al. "Raguwa da Ayyuka na Lafiya ta hanyar Simvastatin a Nondiabetic Coronary Heart Ciwon Marasa lafiya tare da Ba tare da Ciwo na Metabolic: Ƙididdigar Rukuni na Nazarin Scandinavian Simvastatin Survival Study (4S)." Ciwon sukari Care 27 (2004): 1735-40.
Rosenson, Robert S. "Bayani na Jiyya na Hypercholesterolemia." UpToDate.com. 2008. UpToDate. 30 Mar2008 (biyan kuɗi)
Rosenson, Robert S. "Babban Sakatare na Dyslipidemia." UpToDate.com. 2008. UpToDate. 26 Apr 2008. (biyan kuɗi)
"Rahoton uku game da Shirin Kwalejin Cholesterol ta Kasa (NCEP) Panel na Kwararru kan Bincike, Bincike, da Kula da Cholesterol na Cutar Babba a Adult (Adult Treatment Panel III) Report na karshe." Yanayi 106 (2002): 3143.
Zieve, FJ, MF Kalin, SL Schewartz, MR Jones, da WL Bailey. "Sakamakon Glucose-Reduction Effect of WelChol Study (GLOWS): A Randomed, Double-Blind, Nazarin Pilot Sarrafawa ta hanyar gyare-gyaren nazarin Halin Colesevelam Hydrochloride a kan Glycemic Control a cikin Abubuwa da Type 2 Ciwon sukari." Clinical Therapeutics 29 (2007): 74-83.